XML 74 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity (Tables)
6 Months Ended
Jun. 30, 2014
Equity [Abstract]  
Summary of Stock Option Activity

The following table summarizes stock option activity for the six months ended June 30, 2014:

 

     Number of
Options
    Weighted
Average
Exercise Price
     Weighted
Average
Remaining
Contractual Term
(in years)
     Aggregate Intrinsic
Value (1)
 

Outstanding at December 31, 2013

     6,614,534      $ 22.12         

Granted

     798,307      $ 74.77         

Exercised

     (812,059   $ 10.71         

Forfeited

     (179,472   $ 51.62         

Expired

     (243   $ 48.18         
  

 

 

         

Outstanding at June 30, 2014

     6,421,067      $ 29.28         6.62       $ 308.6   
  

 

 

         

Vested and exercisable at June 30, 2014

     4,164,218      $ 17.71         5.55       $ 247.2   
  

 

 

         

 

(1)  The aggregate intrinsic value is calculated as the pre-tax difference between the weighted average exercise price of the underlying awards and the closing price per share of $77.08 of the Company’s common stock on June 30, 2014. The calculation excludes any awards with an exercise price higher than the closing price of the Company’s common stock on June 30, 2014. The amounts are presented in millions.
Summary of Restricted Stock Units

Restricted Stock Units

The following table summarizes restricted stock unit activity for the six months ended June 30, 2014:

 

     Number of
Shares
    Weighted-
Average
Grant-Date
Fair Value
 

Unvested at December 31, 2013

     311,347      $ 52.57   

Granted

     318,569      $ 79.55   

Vested

     (37,952   $ 53.11   

Forfeited

     (36,071   $ 59.18   
  

 

 

   

Unvested at June 30, 2014

     555,893      $ 67.57   
  

 

 

   
Summary of Stock Appreciation Rights Activity

The following table summarizes stock appreciation rights activity for the six months ended June 30, 2014:

 

     Number of
Rights
     Weighted
Average
Exercise Price
     Weighted
Average
Remaining
Contractual Term
(in years)
     Aggregate Intrinsic
Value (1)
 

Outstanding at December 31, 2013

     806,116       $ 23.98         

Granted

     —         $ —           

Exercised

     —         $ —           

Forfeited

     —         $ —           
  

 

 

          

Outstanding at June 30, 2014

     806,116       $ 23.98         7.38       $ 42.8   
  

 

 

          

Vested and exercisable at June 30, 2014

     500,767       $ 23.98         7.32       $ 26.6   
  

 

 

          

 

(1)  The aggregate intrinsic value is calculated as the pre-tax difference between the weighted average exercise price of the underlying awards and the closing price per share of $77.08 of the Company’s common stock on June 30, 2014. The calculation excludes any awards with an exercise price higher than the closing price of the Company’s common stock on June 30, 2014. The amounts are presented in millions.
Schedule of Black-Scholes Assumptions Used for Stock Options

 The Black-Scholes assumptions used to estimate the fair value of stock options granted during the period were as follows:

 

     Three Months Ended
June 30,
   Six Months Ended
June 30,
     2014    2013    2014    2013

Risk-free interest rate

   1.65-1.77%    0.73-1.55%    1.57-1.77%    0.73-1.55%

Estimated term (in years)

   5.09-5.50    5.25-5.50    5.09-5.50    5.24-5.50

Estimated volatility

   60-61%    73-75%    60-64%    68-75%

Estimated dividend yield

   —      —      —      —  
Schedule of Black-Scholes Assumptions Used in Estimating Fair Value of Shares Issued under ESPP

The fair value of shares issued under the ESPP was estimated on the commencement date of the offering period using the Black-Scholes model and the following assumptions:

 

     Three Months Ended
June 30, 2014
    Six Months Ended
June 30, 2014
 

Risk-free interest rate

     0.06     0.06

Estimated term (in years)

     0.50        0.50   

Estimated volatility

     53     53

Estimated dividend yield

     —          —     
Schedule of Stock-Based Compensation Expense

Stock-based compensation expense was as follows:

 

     Three Months Ended
June 30,
     Six Months Ended
June 30,
 
     2014      2013      2014      2013  

Stock-based compensation expense recognized as:

           

R&D expense

   $ 4,503       $ 3,619       $ 8,625       $ 7,437   

SG&A expense

     6,678         4,512         12,217         8,990   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 11,181       $ 8,131       $ 20,842       $ 16,427